Results 51 to 60 of about 1,880,763 (299)

Tumor-infiltrating lymphocyte therapy: therapeutic advances and prospects

open access: yesVisualized Cancer Medicine
Tumor-infiltrating lymphocyte (TIL) therapy has evolved from a pioneering experimental approach to a clinically validated treatment strategy, underscored by the recent approval of lifileucel (Amtagvi) by the Food and Drug Administration (FDA) for ...
Sarker Drishty Badhon   +3 more
doaj   +1 more source

Tumor Infiltrating T Lymphocyte and Macrophage Count Associations with Obesity Status reported as median counts (interquartile range) unless otherwise specified.

open access: yes, 2016
Tumor Infiltrating T Lymphocyte and Macrophage Count Associations with Obesity Status reported as median counts (interquartile range) unless otherwise specified.
Michael Feldman (244700)   +3 more
core   +1 more source

Supplementary Figure from COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes

open access: yes, 2022
Supplementary Figure from COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating ...
Nicholas Drovetto (15109319)   +5 more
core   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Tumor Infiltrating Lymphocytes in Different Stages of Malignant Melanoma and Correlation with Tumor Stage and Other Prognostic Factors: A Retrospective Multicenter Study

open access: yesMiddle East Journal of Cancer, 2017
Background: Melanoma is one of the most immunogenic tumors that causes a significant immune response. Tumor infiltrating lymphocytes are an important part of this response. Tumor infiltrating lymphocytes are lymphocytes in close association with tumor
Alireza Ghanadan   +3 more
doaj  

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Tumor-infiltrating neutrophils predict poor survival of non-functional pancreatic neuroendocrine tumor. Supplementary material

open access: yes, 2020
Supplementary material for the manuscript "Tumor-infiltrating neutrophils predict poor survival of non-functional pancreatic neuroendocrine tumor".
Wen-Quan Wang (8631932)   +14 more
core   +1 more source

Immunobiology of IL-17A in human colorectal cancer [PDF]

open access: yes, 2015
During the last decade tumor infiltration by immune cells has been recognized as a key factor determining clinical outcome. Whereas the presence within tumor tissues of defined lymphocytic populations, including cytotoxic CD8+ T cells and IFN-gamma ...
Amicarella, Francesca
core   +1 more source

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

Protocol for simultaneous analysis of peripheral and intratumoral lymphocyte function by flow cytometry

open access: yesSTAR Protocols, 2023
Summary: Here, we present a protocol for the simultaneous analysis of peripheral and intratumoral lymphocyte function by flow cytometry. Using tumor and blood samples from patients with colorectal cancer, we describe steps for tumor digestion, pre ...
Susy Daumoine   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy